SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. (Q34547626)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. |
scientific article |
Statements
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia (English)
Constanze Schneider
Thomas Oellerich
Sarah-Marie Schwarz
Dominique Thomas
Robert Flick
Hanibal Bohnenberger
Lena Stegmann
Anjali Cremer
Margarethe Martin
Julian Lohmeyer
Christoph Schliemann
Wolfgang E Berdel
Eva Wardelmann
Gerd Geisslinger
Nerea Ferreirós
Oliver T Keppler
Wolfgang Hartmann
Martin-Leo Hansmann
19 December 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference